- Home
- ESPR vs SBT Comparison
ESPR vs SBT Comparison
Compare ESPR & SBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- SBT
- Stock Information
- Founded
- ESPR 2008
- SBT 1984
- Country
- ESPR United States
- SBT United States
- Employees
- ESPR N/A
- SBT N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- SBT Savings Institutions
- Sector
- ESPR Health Care
- SBT Finance
- Exchange
- ESPR Nasdaq
- SBT Nasdaq
- Market Cap
- ESPR 305.0M
- SBT 249.0M
- IPO Year
- ESPR 2013
- SBT 2017
- Fundamental
- Price
- ESPR $1.50
- SBT $4.56
- Analyst Decision
- ESPR Buy
- SBT
- Analyst Count
- ESPR 7
- SBT 0
- Target Price
- ESPR $6.36
- SBT N/A
- AVG Volume (30 Days)
- ESPR 3.5M
- SBT 20.2K
- Earning Date
- ESPR 03-04-2025
- SBT 04-23-2025
- Dividend Yield
- ESPR N/A
- SBT N/A
- EPS Growth
- ESPR N/A
- SBT N/A
- EPS
- ESPR N/A
- SBT 0.04
- Revenue
- ESPR $332,314,000.00
- SBT $66,063,000.00
- Revenue This Year
- ESPR $5.51
- SBT N/A
- Revenue Next Year
- ESPR $1.42
- SBT N/A
- P/E Ratio
- ESPR N/A
- SBT $115.25
- Revenue Growth
- ESPR 185.66
- SBT N/A
- 52 Week Low
- ESPR $1.47
- SBT $4.40
- 52 Week High
- ESPR $3.94
- SBT $5.97
- Technical
- Relative Strength Index (RSI)
- ESPR 34.95
- SBT 40.52
- Support Level
- ESPR $1.57
- SBT $4.61
- Resistance Level
- ESPR $1.86
- SBT $4.64
- Average True Range (ATR)
- ESPR 0.13
- SBT 0.07
- MACD
- ESPR -0.01
- SBT -0.00
- Stochastic Oscillator
- ESPR 7.69
- SBT 4.81
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About SBT Sterling Bancorp Inc.
Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.